MedTrace Logo

Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer

NCT01325142 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 271

Last updated 2014-12-02

No results posted yet for this study

Summary

This study seeks to identify risk factors associated with the development of a jaw condition seen in patients with cancer treated with certain medications.

Conditions

  • Bone Diseases
  • Metastases
  • Osteonecrosis
  • Bisphosphonate-Associated Osteonecrosis of the Jaw

Sponsors & Collaborators

Principal Investigators

  • Catherine Van Poznak, MD · University of Michigan

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01325142 on ClinicalTrials.gov